Boehringer Ingelheim: all 2,305 studies
Page 22 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid TumoursCompletedNCT01951846Phase 1
- GLORIA-AF Registry Program (Phase II/III)CompletedNCT01937377
- Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)Approved for marketingNCT01931306
- A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic CancerCompletedNCT01905111Phase 1
- Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed ConditionsCompletedNCT01897597Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes MellitusCompletedNCT01874483Phase 1
- Open Label Trial to Compare BI 207127 to Telaprevir in HCV PatientsWithdrawnNCT01858961Phase 3
- Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of AgeWithdrawnNCT01773174Phase 2
- Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male VolunteersCompletedNCT01707940Phase 1
- Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XXCompletedNCT01652742Phase 1
- Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic PatientsCompletedNCT01651598Phase 1
- Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.CompletedNCT01650155Phase 1
- Afatinib Expanded Access ProgramApproved for marketingNCT01649284
- Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male VolunteersCompletedNCT01638598Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic SubjectsCompletedNCT01629849Phase 1
- A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C InfectionWithdrawnNCT01608737Phase 3
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CLCompletedNCT01587417Phase 1
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XXCompletedNCT01587391Phase 1
- Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male VolunteersCompletedNCT01541488Phase 1
- Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male VolunteersCompletedNCT01510782Phase 1
- Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male VolunteersCompletedNCT01480648Phase 1
- Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled CorticosteroidsWithdrawnNCT01458912Phase 2
- Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy AloneWithdrawnNCT01458886Phase 2
- Olodaterol Bridging Study in AsthmaWithdrawnNCT01428622Phase 2
- Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)CompletedNCT01423721Phase 1
- Phase I Study of AbGn-168H in Healthy Male VolunteersCompletedNCT01378364Phase 1
- Ambroxol Spray Sore Throat StudyCompletedNCT01361802Phase 2
- To Assess the Bioequivalence of Brotizolam Tablets 250 Mcg vs. Lendormin Tablets 250 Mcg Administered to Healthy Adult VolunteersCompletedNCT01361022Phase 1
- Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.CompletedNCT01343719Phase 1
- A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic CancerCompletedNCT01335269Phase 1
- Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy VolunteersCompletedNCT01309139Phase 1
- Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.CompletedNCT01291732Phase 1
- Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without FoodCompletedNCT01286571Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 DiabetesCompletedNCT01282970Phase 1
- Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.WithdrawnNCT01276990Phase 1
- Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian VolunteersCompletedNCT01216384Phase 1
- Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.CompletedNCT01215773Phase 1
- LUX Lung Special Access Scheme Australia Named Patient Use (NPU)Approved for marketingNCT01209650
- Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the KneeTerminatedNCT01207973Phase 1
- A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male VolunteersCompletedNCT01205373Phase 1
- Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male SubjectsCompletedNCT01195688Phase 1
- Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823CompletedNCT01189175Phase 1
- Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.CompletedNCT01170637Phase 1
- Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy VolunteersCompletedNCT01146886Phase 1
- To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution (Powder in Bottle).TerminatedNCT01145014Phase 1
- to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy VolunteersCompletedNCT01134965Phase 1
- Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of SeasonCompletedNCT01007721Phase 2
- Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure RiseCompletedNCT00946829
- An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.Approved for marketingNCT00933205
- MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® TreatmentCompletedNCT00885027
- Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous InsufficiencyCompletedNCT00855179Phase 3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in PsoriasisCompletedNCT00848055Phase 1
- Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV CohortWithdrawnNCT00805857
- A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal CancerCompletedNCT00801294Phase 2
- Phase I Study of BI 831266 in Patients With Advanced Solid TumoursCompletedNCT00756223Phase 1
- Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's DiseaseCompletedNCT00752388
- BI 44370 TA in Acute Migraine AttackCompletedNCT00751803Phase 2
- Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine AttacksCompletedNCT00743015Phase 1
- Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid TumorsCompletedNCT00730821Phase 1
- Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive BronchitisWithdrawnNCT00726479Phase 2
- Phase II Study of BI 2536 in Prostate CancerCompletedNCT00706498Phase 2
- BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid LeukaemiaCompletedNCT00701766Phase 2
- BI 811283 in Various Solid TumoursCompletedNCT00701324Phase 1
- Tiotropium and Salmeterol PK Study in COPD PatientsCompletedNCT00673478Phase 3
- Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential HypertensionCompletedNCT00638911
- Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD PatientsCompletedNCT00620516
- Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)CompletedNCT00617019
- Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)CompletedNCT00615563
- Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced PopulationCompletedNCT00614302
- Special Survey on PD Patients With Renal DysfunctionCompletedNCT00613756
- Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational StudyCompletedNCT00612885
- Sodium Picosulphate vs. Placebo in Functional ConstipationCompletedNCT00576810Phase 3
- 4 Weeks Treatment of Type II Diabetic Patients With BI 44847CompletedNCT00558909Phase 1
- Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the LegsCompletedNCT00557258
- Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaCompletedNCT00540163
- Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesCompletedNCT00539487
- Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of LifeCompletedNCT00539461
- Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's DiseaseCompletedNCT00539214
- Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPDCompletedNCT00535366Phase 2
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.CompletedNCT00388882Phase 4
- A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLSCompletedNCT00375284Phase 4
- An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent AsthmaCompletedNCT00365560Phase 2
- Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood DisturbancesCompletedNCT00356096Phase 4
- A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLSCompletedNCT00349531Phase 4
- Profile of Depressive Symptoms in Parkinsons DiseaseCompletedNCT00349310
- Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.CompletedNCT00347295Phase 3
- Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe PsoriasisCompletedNCT00333411Phase 2
- Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With HypertensionCompletedNCT00326768Phase 3
- General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and TreatmentCompletedNCT00319813
- Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
- Case-Control Viramune (Nevirapine) Toxicogenomics StudyCompletedNCT00310843
- Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated PatientsTerminatedNCT00294372Phase 2
- A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00292448Phase 2
- Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)CompletedNCT00292435Phase 3
- Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
- A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)CompletedNCT00279747Phase 3
- Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3
- Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) PatientsCompletedNCT00275457Phase 3
- 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining StudyCompletedNCT00275444Phase 2